Matthew Wood

Matthew Wood

OPDC Investigator

Matthew studies RNA biology and therapeutics for degenerative disorders of the nervous system. Interests of the group include the investigation of gene 'knock-down' therapeutic methods for dominantly inherited Parkinson's caused by alpha synuclein and LRRK2 mutations, and investigating the role of newly discovered very short RNA molecules (microRNAs) in the normal growth and development of dopamine neurons and in the development of dopamine neurons and in the development of Parkinson's pathology.

Publications

View full profile